S'ha dissenyat i aplicat un estudi de clima laboral anònim entre tots els professionals de l'Hospital perquè expressin els seus pensaments, valorin l’organització i ajudin a millorar-la.
As well as research into primary immunodeficiencies, it is also conducting research to identify molecular bases in cases of less serious combined immunodeficiencies that have not yet been characterised by exogenous analysis or high-performance sequencing techniques, next generation sequencing (NGS).
The Diagnostic Immunology research group is working on two main lines of research. On the one hand, it is studying autoimmunity with the aim of understanding how the lack of immune tolerance leads to autoimmune diseases in specific organs. One the other hand, it is researching primary immunodeficiencies to improve diagnostic tools based on combinations of functional and molecular tests.
The group’s basic and clinical lines of research surround, above all, the fields of inflammation and repair, respiratory insufficiency and tissue hypoxia. These fields complement one another and are connected through the study of conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, infections, transplants, pulmonary hypertension and sleep-related breathing disorders.
The group’s basic and clinical research activity, above all, surrounds the fields of inflammation and repair, respiratory insufficiency and tissue hypoxia, and these fields complement one another and are connected through the study of conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, infections, transplants, pulmonary hypertension and sleep-related breathing disorders.
The Neurovascular Disorders research group’s lines of research cover prevention, treatment and repair aspects, also working on the identification of biomarkers in the pathology.
Focusing on embolisms from a basic and translational point of view, the research group on neurovascular disorders is investigating all stages of the illness.
The group is working on understanding the mechanisms involved in renal physiopathology. One of its main lines of research is the role that androgens play. Another important part of the group’s efforts is the early detection of biomarkers for kidney dysfunction, with high performance proteomic analysis and blood and urine samples from patients transplanted under different immunosuppressant regimes.
Clinical Nanomedicine and Advanced Therapies Research Centre. Renal Physiopathology
One of the main focuses of our laboratory is research into the role androgens play in renal physiopathology, as well as early detection of specific and sensitive biomarkers for kidney dysfunction. The Hospital’s Nephrology and Paediatric Nephrology units participate in the group.
The research group focuses on shedding light on the molecular mechanisms behind the neurone cell death that occurs in neurodegenerative diseases, with the aim of finding a cure for this group of neurological, debilitating and incurable disorders. A large part of the group’s work is on Parkinson's disease, a specific neurodegenerative disorder that is mainly characterised by the degeneration of a specific type of neurone that has been identified as automatically limiting a small area of the brain known as substantia nigra pars compacta, which produces the neurotransmitter dopamine.
The Neurodegenerative Diseases research group focuses on getting to know and understanding the mechanisms involved in neurone death in brain degeneration disorders. Mainly focusing on Parkinson's disease, the group was formed with the support of ICREA (Catalan Institution for Research and Advanced Studies) and the European Commission’s Marie Curie Research Grants Scheme. It is also part of the Red Española de Excelencia en Enfermedades Neurodegenerativas (CIBERNED - the Spanish Network of Excellence in Neurodegenerative Diseases).
The group directs its research towards possible gene therapy strategies for autoimmune and neurodegenerative disorders, especially those associated with ageing. This type of disorder affects the central nervous system (CNS), one of the current challenges in relation to their treatment. There are no effective treatments to cure these illnesses. They are complex and there is the added element of not being able to easily access the CNS and treat them with classic drugs.
Gene Therapy and the Nervous System
The field of Medicine still has many challenges to resolve, especially in complex diseases with many factors involved, both genetic and environmental. These include neurodegenerative and autoimmune disorders that affect the central nervous system. There are no effective treatments for these conditions. The Gene Therapy and Nervous System research group was therefore created to look for new treatments for autoimmune and neurodegenerative disorders, especially those associated with ageing.
The team’s main aims are to establish synergies between clinics and researchers in the field of musculoskeletal problems, to develop and improve medical and surgical approaches to reconstruction techniques in orthopaedic surgery. This is reflected in lines of research for the study of neuromuscular pathology, paediatric musculoskeletal research, traumatic injuries, septic pathology (articular periprosthetic infection and osteomyelitis) and knee pathology.
Reconstructive Surgery of the Locomotor System
The group’s research deals with musculoskeletal problems to improve treatment results, with lines of research in the fields of paediatric orthopaedics, traumatic injuries, skeletal infections and knee problems.
This group’s lines of research include investigation into biomaterials and bioengineering in surgery, with particular attention on the abdominal wall, colorectal, endocrine, bariatric and metabolic surgery, as well as thoracic surgery.
The General Surgery research group is working to achieve advances in the understanding, diagnosis, treatment and prevention of illnesses included within this specialism. The group’s ultimate goal is to contribute to offering better treatments and results and improving quality.
The Nephrology Teaching Unit has a resident training programme with the following key tracks: extensive training in internal medicine, specific training in nephrology, in-depth knowledge of treatment techniques for renal failure, practical knowledge on diagnosis and therapies in nephrology, and practical knowledge of the role of the nephrologist in community healthcare.
Accredited places: 2
The Nephrology Teaching Unit is led by the Nephrology Department, with participation from the Digestive System, Cardiology, Internal Medicine, Intensive Care Medicine, Infectious Diseases and A&E Departments.